NHS National Pharmaceuticals Transition 2022_1
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 12 Aug 2022
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
United Kingdom: Please refer to Document 3, Schedule8 in the ITO Documents for the list ofpurchasing points
Geochart for 1 buyers and 60 suppliers
1 buyer
- NHS England Leeds
42 suppliers
- Celix Pharma London
- Accord Barnstaple
- Amarox Harrow
- Teva Castleford
- Drreddys Laboratories Beverley
- Morningside Pharmaeuticals Loughborough
- Roma Pharmaceuticals Burton on Trent
- Sandoz Camberley
- Selective Supplies Watford
- Flynn Pharma Stevenage
- Tillomed Laboratories Luton
- Zentiva Pharma Dunmow
- Mercury Pharmaceuticals London
- Glenmark Pharmaceuticals Europe Watford
- Intrapharm Laboratories Maidenhead
- Aspen Pharmacare Maidenhead
- Ranbaxy Uxbridge
- Day Lewis Medical Croydon
- Mylan Hatfield
- Kent Pharma Ashford
- Norgine Pharmaceuticals Uxbridge
- Napp Pharmaceuticals Cambridge
- Neon Healthcare Hertford
- Relonchem Widnes
- Ennogen Healthcare Dartford
- Rosemont Pharmaceuticals Leeds
- Pfizer Tadworth
- B Braun Medical Sheffield
- Flexipharm Austrading Bourne End
- Sintetica London
- Wockhardt Wrexham
- Medac Pharma Stirling
- Roche Products Welwyn Garden City
- Clinigen Healthcare Weybridge
- Piramal Critical Care Chesterfield
- Milpharm South Ruislip
- Chiesi Manchester
- Consilient Health Richmond upon Thames
- Fresenius Kabi Runcorn
- Alturix Milton Keynes
- Panpharma Liverpool
- Macure Pharma Aps Copenhagen
Description
NHS National Pharmaceuticals Transition 2022_1Potential periods of call-offs under theframework agreement:Transition:CESW: 29/07/2022 to 30/09/2023 (14months)LSNE: 29/07/2022 to 31/05/2024 (22months)NWLN: 29/07/2022 to 31/01/2023 (6months)Oral (plus non-parenteral) Products: Allregions: 29/07/2022 to 31/05/2024 (22months)Hospital Only Products:CESW: 29/07/2022 to 30/09/2023 (14months)LSNE: 29/07/2022 to 31/05/2024 (22months)NWLN: 29/07/2022 to 31/01/2023 (6months)
Lot Division
| 1 | CM/PHG/21/5637/00 Transition products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1Offer reference number: CM/PHG/21/5637/00Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Transition: CESW: 29/07/2022 to30/09/2023 (14 months)LSNE: 29/07/2022 to 31/05/2024 (22months)NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 2 | CM/PHG/21/5637/01 Oral (plus non-parenteral) products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1Offer reference number: CM/PHG/21/5637/01Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 3 | CM/PHG/21/5637/02 Hospital Only Products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1Offer reference number: CM/PHG/21/5637/02Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Hospital Only Products: CESW:29/07/2022 to 30/09/2023 (14 months)LSNE: 29/07/2022 to 31/05/2024 (22months)NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
Award Detail
| 1 | Celix Pharma (London)
|
| 2 | Accord (Barnstaple)
|
| 3 | Amarox (Harrow)
|
| 4 | Teva (Castleford)
|
| 5 | Drreddys Laboratories (Beverley)
|
| 6 | Morningside Pharmaeuticals (Loughborough)
|
| 7 | Roma Pharmaceuticals (Burton on Trent)
|
| 8 | Sandoz (Camberley)
|
| 9 | Selective Supplies (Watford)
|
| 10 | Flynn Pharma (Stevenage)
|
| 11 | Tillomed Laboratories (Luton)
|
| 12 | Zentiva Pharma (Dunmow)
|
| 13 | Mercury Pharmaceuticals (London)
|
| 14 | Glenmark Pharmaceuticals Europe (Watford)
|
| 15 | Intrapharm Laboratories (Maidenhead)
|
| 16 | Aspen Pharmacare (Maidenhead)
|
| 17 | Ranbaxy (Uxbridge)
|
| 18 | Day Lewis Medical (Croydon)
|
| 19 | Mylan (Hatfield)
|
| 20 | Kent Pharma (Ashford)
|
| 21 | Accord (Barnstaple)
|
| 22 | Norgine Pharmaceuticals (Uxbridge)
|
| 23 | Drreddys Laboratories (Beverley)
|
| 24 | Napp Pharmaceuticals (Cambridge)
|
| 25 | Selective Supplies (Watford)
|
| 26 | Neon Healthcare (Hertford)
|
| 27 | Zentiva Pharma (Dunmow)
|
| 28 | Glenmark Pharmaceuticals Europe (Watford)
|
| 29 | Aspen Pharmacare (Maidenhead)
|
| 30 | Day Lewis Medical (Croydon)
|
| 31 | Relonchem (Widnes)
|
| 32 | Ennogen Healthcare (Dartford)
|
| 33 | Rosemont Pharmaceuticals (Leeds)
|
| 34 | Kent Pharma (Ashford)
|
| 35 | Accord (Barnstaple)
|
| 36 | Pfizer (Tadworth)
|
| 37 | Amarox (Harrow)
|
| 38 | Teva (Castleford)
|
| 39 | Drreddys Laboratories (Beverley)
|
| 40 | Morningside Pharmaeuticals (Loughborough)
|
| 41 | B Braun Medical (Sheffield)
|
| 42 | Flexipharm Austrading (Bourne End)
|
| 43 | Tillomed Laboratories (Luton)
|
| 44 | Sintetica (London)
|
| 45 | Mercury Pharmaceuticals (London)
|
| 46 | Glenmark Pharmaceuticals Europe (Watford)
|
| 47 | Aspen Pharmacare (Maidenhead)
|
| 48 | Ranbaxy (Uxbridge)
|
| 49 | Wockhardt (Wrexham)
|
| 50 | Medac Pharma (Stirling)
|
| 51 | Roche Products (Welwyn Garden City)
|
| 52 | Clinigen Healthcare (Weybridge)
|
| 53 | Piramal Critical Care (Chesterfield)
|
| 54 | Milpharm (South Ruislip)
|
| 55 | Chiesi (Manchester)
|
| 56 | Consilient Health (Richmond upon Thames)
|
| 57 | Fresenius Kabi (Runcorn)
|
| 58 | Alturix (Milton Keynes)
|
| 59 | Panpharma (Liverpool)
|
| 60 | Macure Pharma Aps (Copenhagen)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-032338
- FTS 022307-2022